Alliancebernstein L.P. Atri Cure, Inc. Transaction History
Alliancebernstein L.P.
- $287 Billion
- Q3 2024
A detailed history of Alliancebernstein L.P. transactions in Atri Cure, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 3,972,448 shares of ATRC stock, worth $122 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,972,448
Previous 4,204,979
5.53%
Holding current value
$122 Million
Previous $95.7 Million
16.33%
% of portfolio
0.04%
Previous 0.03%
Shares
23 transactions
Others Institutions Holding ATRC
# of Institutions
212Shares Held
49.7MCall Options Held
12KPut Options Held
7.2K-
Vanguard Group Inc Valley Forge, PA4.66MShares$143 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$142 Million0.0% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.83MShares$87 Million1.47% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.79MShares$85.7 Million0.5% of portfolio
-
Macquarie Group LTD Australia, C32.38MShares$73.3 Million0.07% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.43B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...